Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Immuron runs a Biotechnology Research operation from Melbourne, Victoria. Ownership is publicly held; it publishes at immuron.com. The record carries two addresses across two office countries. The record counts 17 people. One Australian registration (ABN) is a confirmed match. The latest round on record is Grant at US$2.3M. The record links nine similar brands, most of them in Biotechnology Research.
ABN80063114045
| IMMURON LIMITED | ABN 80063114045 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases.
ACCEPTABLE USE POLICY We welcome your comments on our page but we ask that you help us comply with the Therapeutic Goods Advertising Code. Please consider these guidelines before commenting. We will remove any comments that may result in us breaching the Code. We love when you comment and tag your friends and family on our posts but we ask that you do not:
- endorse our product if you are:
o an employee or contractor of a government authority, a hospital or a healthcare facility o a health practitioner, health professional or medical researcher o involved with the production, sale, supply or marketing of our product o not using your own name on this social media platform
- imply that a government authority, a hospital or a healthcare facility endorse our product
- make comments about how a product works for you outside of its intended purpose, as these comments can be dangerous or misleading - our products are developed for particular purposes, as stated on the label and/or in our advertising
- make comments about serious conditions, diseases, ailments or defects, such as comments about how a product helped with your treatment of a serious disease or how it will relieve a tagged person's serious condition
We also have an obligation to make sure any advertisements we make, including endorsements and testimonials, are not misleading. Therefore we promise to disclose:
- where a person has been, or will be, compensated for making a testimonial
- where we have actors making the testimonial, such as in cases where the original person who made the testimonial does not want to appear in our advertisement
- where the person making the testimonial is an immediate family member of anyone employed by our company.
| Countries | 2 |
|---|---|
| Primary country | AU |
All codes: AU US
| Rounds | 4 |
|---|---|
| Axis | 2024 to 2027 |
| Grant · 16 Sep 2024 | US$ 2.3M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Victoria entity on the ABR. IMMURON LIMITED (ABN 80 063 114 045), high confidence.
The record holds 17 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Two addresses on record across 2 countries. Primary: Suite 10- 25 Chapman Street, Blackburn North, Melbourne, Victoria 3130.
Four rounds. Latest 16 September 2024: grant, US$2,300,000.
7 profiles list Immuron as a peer — 73rd percentile in Biotechnology Research. It lists ten peers of its own. Coffee Microcaps and Anatara Lifesciences Ltd list it back.